Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Vanilla on Hypoxic Intermittent Events in Premature Infants

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Linkul este salvat în clipboard
stareRecrutare
Sponsorii
Université de Sherbrooke

Cuvinte cheie

Abstract

The purpose of this study is to evaluate the effect of vanilla odor on hypoxic intermittent events in premature infants born between 32.0 and 33.6 weeks of gestational age.

Descriere

A weekly screening will be done on all new hospitalized infants at the neonatal care unit of the CHUS born between 32.0 and 33.6 weeks of gestational age. At the beginning of their 2nd week in the neonatal care unit, infant's medical record will be consult for inclusion and exclusion criteria. At this moment, no information will be noted. Then, team research will discuss with neonatologist to have their opinion concerning the inclusion of a patient in the study. If they agree, the doctor or the nurse having a therapeutic link with the infant will ask parents' infant if they agree to meet the research team to discuss about the research project. Once the agreement will be obtained, parents will be approached by a member of the research team. Project will be explained, questions will be answered and consent form will be obtained. When an infant will be enrolled in the study, a code will be attributed to him and a randomization will established the order of the intervention.

Option A) night 1: a 12h cardiorespiratory recording with vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording without vanilla OR Option B): night 1: a 12h cardiorespiratory recording without vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording recording with vanilla.

A 3h polysomnography will be done in a sub-sample of 10-15 infants in the morning by the night 1 and 3 according by the pre-existing condition of vanilla or not.

All data will be entered in a secured database and a double checked will be done by team members to assess the accuracy.

Datele

Ultima verificare: 06/30/2019
Primul depus: 12/03/2015
Inscriere estimată trimisă: 12/13/2015
Prima postare: 12/14/2015
Ultima actualizare trimisă: 07/10/2019
Ultima actualizare postată: 07/14/2019
Data actuală de începere a studiului: 08/31/2015
Data estimată de finalizare primară: 11/30/2019
Data estimată de finalizare a studiului: 05/31/2020

Stare sau boală

Premature Birth
Neonatal Hypoxic Conditions

Intervenție / tratament

Other: Night-vanilla

Fază

-

Grupuri de brațe

BraţIntervenție / tratament
Experimental: Night-vanilla
Intervention = exposition to vanilla scent A quantity of 2 ml of a saturated vanilla solution (2% vanillin) will be applied on premature pyjamas infant's, close to his face (on each shoulder and on the upper chest).
Other: Night-vanilla
A 12-hour continuous recording for monitoring hemoglobin oxygen saturation, electrocardiogram and respiratory movements will be performed while the infant is exposed to vanilla scent (from vanilla solution on the infant's pyjamas). In addition, a 3-hour polysomnography will be done in a sub-sample on the morning following the night recording with vanilla solution.
No Intervention: Night-no vanilla
The only difference with the experimental arm is the absence of vanilla (usual, standard care)

Criterii de eligibilitate

Sexe eligibile pentru studiuAll
Acceptă voluntari sănătoșida
Criterii

Inclusion Criteria:

- Infants born between 32.0 and 33.6 weeks of gestational age;

- Postnatal age between 3 and 4 weeks;

- No current respiratory or ventilatory support;

- Stable state for at least the last 48 hours;

- Parental consent to enroll in the study.

Exclusion Criteria:

- Respiratory diseases other than apnea;

- Intraventricular hemorrhage grade 3 or 4 OR leukomalacia;

- Chromosomal abnormality;

- Congenital malformations which may result in cardiorespiratory or neurodevelopmental abnormality;

- Clinical deterioration during the study.

Rezultat

Măsuri de rezultate primare

1. Number of hypoxic intermittent events [night 1 and 3]

Number of changes in the number of hypoxic intermittent events

Măsuri de rezultate secundare

1. Duration of oxygen saturation under 80% and under 90% [night 1 and 3]

Change in the duration of oxygen saturation under 80% and under 90%

2. Number of bradycardias [night 1 and 3]

Change in the number of bradycardias

3. Duration of periodic breathing [night 1 and 3]

Change in the duration of periodic breathing

4. Heart rate variability [night 1 and 3]

Change in heart rate variability

5. Respiratory rate variability [night 1 and 3]

Change in respiratory rate variability

Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge